OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity
Negin Soghli, Gordon A. Ferns, Fatemeh Sadeghsoltani, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115094-115094
Closed Access | Times Cited: 27
Negin Soghli, Gordon A. Ferns, Fatemeh Sadeghsoltani, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115094-115094
Closed Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance
Ahmed S. Doghish, Maghawry Hegazy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154442-154442
Closed Access | Times Cited: 50
Ahmed S. Doghish, Maghawry Hegazy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154442-154442
Closed Access | Times Cited: 50
MicroRNAs; their therapeutic and biomarker properties
Shahnam Azizi‐Dargahlou, Marcello Iriti, Mahin Pouresmaeil, et al.
Cellular Molecular and Biomedical Reports (2023) Vol. 3, Iss. 2, pp. 73-88
Open Access | Times Cited: 50
Shahnam Azizi‐Dargahlou, Marcello Iriti, Mahin Pouresmaeil, et al.
Cellular Molecular and Biomedical Reports (2023) Vol. 3, Iss. 2, pp. 73-88
Open Access | Times Cited: 50
Current Status and Prospects of Clinical Treatment of Osteosarcoma
Zong-Yuan Jiang, Ji‐Bin Liu, Xiaofeng Wang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 44
Zong-Yuan Jiang, Ji‐Bin Liu, Xiaofeng Wang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 44
Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
Ziyu Ji, Jianlin Shen, Yujian Lan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 32
Ziyu Ji, Jianlin Shen, Yujian Lan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 32
Anti-Invasive and Anti-Migratory Effects of Ononin on Human Osteosarcoma Cells by Limiting the MMP2/9 and EGFR-Erk1/2 Pathway
Guowei Gong, Kumar Ganesan, Qingping Xiong, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 758-758
Open Access | Times Cited: 20
Guowei Gong, Kumar Ganesan, Qingping Xiong, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 758-758
Open Access | Times Cited: 20
Nanostructured system based on hydroxyapatite and curcumin: A promising candidate for osteosarcoma therapy
Jéssica Pauline Nunes Marinho, Natália P. Neme, Matheus J. S. Matos, et al.
Ceramics International (2023) Vol. 49, Iss. 12, pp. 19932-19949
Open Access | Times Cited: 11
Jéssica Pauline Nunes Marinho, Natália P. Neme, Matheus J. S. Matos, et al.
Ceramics International (2023) Vol. 49, Iss. 12, pp. 19932-19949
Open Access | Times Cited: 11
Triple DNAzyme cleavage mediated signal cascade for sensitive and reliable Kawasaki disease related microRNA analysis
Qingguo Ruan, B.-M. Zhao
Analytical Biochemistry (2025), pp. 115887-115887
Closed Access
Qingguo Ruan, B.-M. Zhao
Analytical Biochemistry (2025), pp. 115887-115887
Closed Access
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p
Shuchi Xia, Yun Liang, Yuqing Shen, et al.
Journal of bone oncology (2023) Vol. 41, pp. 100490-100490
Open Access | Times Cited: 10
Shuchi Xia, Yun Liang, Yuqing Shen, et al.
Journal of bone oncology (2023) Vol. 41, pp. 100490-100490
Open Access | Times Cited: 10
Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
Y Xiang, Yingxin Yang, Jia Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Y Xiang, Yingxin Yang, Jia Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?
Mostafa Vaghari‐Tabari, Davoud Jafari-Gharabaghlou, Mozafar Mohammadi, et al.
Biological Trace Element Research (2023) Vol. 202, Iss. 5, pp. 1878-1900
Closed Access | Times Cited: 9
Mostafa Vaghari‐Tabari, Davoud Jafari-Gharabaghlou, Mozafar Mohammadi, et al.
Biological Trace Element Research (2023) Vol. 202, Iss. 5, pp. 1878-1900
Closed Access | Times Cited: 9
Research progress on the role of lncRNA, circular RNA, and microRNA networks in regulating ferroptosis in osteosarcoma
Chunlu Yan, Yinnan Dou, Ruoliu Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116924-116924
Open Access | Times Cited: 2
Chunlu Yan, Yinnan Dou, Ruoliu Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116924-116924
Open Access | Times Cited: 2
Target recycle initiated entropy driven assembly strategy for sensitive, enzyme-free, and portable miRNA detection
Zhijun Jiang, Zhiyuan Liu
Analytical Biochemistry (2024) Vol. 693, pp. 115593-115593
Closed Access | Times Cited: 2
Zhijun Jiang, Zhiyuan Liu
Analytical Biochemistry (2024) Vol. 693, pp. 115593-115593
Closed Access | Times Cited: 2
Machine learning and experimental analyses identified miRNA expression models associated with metastatic osteosarcoma
Samira Abedi, Ali Behmanesh, Farid Najd Mazhar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167357-167357
Closed Access | Times Cited: 1
Samira Abedi, Ali Behmanesh, Farid Najd Mazhar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167357-167357
Closed Access | Times Cited: 1
Exploring Circulating MiRNA Signature for Osteosarcoma Detection; Bioinformatics-Based Analyzing and Validation
Negar Heidari, Massoud Vosough, Abolfazl Bagherifard, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155615-155615
Closed Access | Times Cited: 1
Negar Heidari, Massoud Vosough, Abolfazl Bagherifard, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155615-155615
Closed Access | Times Cited: 1
hsa-miR-199b-3p suppresses osteosarcoma progression by targeting CCDC88A, inhibiting epithelial-to-mesenchymal transition, and Wnt/beta-catenin signaling pathway
Dongsheng Zhu, Qi Han, Hongqi Zhu
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Dongsheng Zhu, Qi Han, Hongqi Zhu
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma
Jie Shao, Yi Zhang, Zhu Chang, et al.
Acta Biochimica et Biophysica Sinica (2023)
Open Access | Times Cited: 3
Jie Shao, Yi Zhang, Zhu Chang, et al.
Acta Biochimica et Biophysica Sinica (2023)
Open Access | Times Cited: 3
miR-488-3p Represses Malignant Behaviors and Facilitates Autophagy of Osteosarcoma Cells by Targeting Neurensin-2
Chao Yun, Jincai Zhang, Morigele Morigele
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 10, pp. 1264-1275
Closed Access | Times Cited: 2
Chao Yun, Jincai Zhang, Morigele Morigele
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 10, pp. 1264-1275
Closed Access | Times Cited: 2
Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma
Xiaofang Hong, Ribin Fu
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295364-e0295364
Open Access | Times Cited: 2
Xiaofang Hong, Ribin Fu
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295364-e0295364
Open Access | Times Cited: 2
miR‐1246 promotes osteosarcoma cell migration via NamiRNA‐enhancer network dependent on Argonaute 2
Shuai Yang, Qingping Zou, Ying Liang, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access
Shuai Yang, Qingping Zou, Ying Liang, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access
MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway in Vivo and in Vitro
Yun-Teng Hu, Jianjun Li, Chun Liu, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access
Yun-Teng Hu, Jianjun Li, Chun Liu, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access
MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1
Mao Wang, Weina Li, Guohui Han, et al.
Protein and Peptide Letters (2024) Vol. 31, Iss. 7, pp. 559-568
Closed Access
Mao Wang, Weina Li, Guohui Han, et al.
Protein and Peptide Letters (2024) Vol. 31, Iss. 7, pp. 559-568
Closed Access
Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma
Chengran Wang, Yihong Zhang, Weihui Kong, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8641-8660
Open Access
Chengran Wang, Yihong Zhang, Weihui Kong, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8641-8660
Open Access
MicroRNA signatures in osteosarcoma: diagnostic insights and therapeutic prospects
Mritunjoy Dey, Palina Skipar, Ewa Bartnik, et al.
Molecular and Cellular Biochemistry (2024)
Open Access
Mritunjoy Dey, Palina Skipar, Ewa Bartnik, et al.
Molecular and Cellular Biochemistry (2024)
Open Access
Nucleic Acid Therapeutics in Cancer Biology
Pallabi Sengupta, Nilanjan Banerjee, Anindya Dutta, et al.
(2023), pp. 321-348
Closed Access | Times Cited: 1
Pallabi Sengupta, Nilanjan Banerjee, Anindya Dutta, et al.
(2023), pp. 321-348
Closed Access | Times Cited: 1
Metformin sensitises osteosarcoma to chemotherapy <em>via</em> the IGF-1R/miR-610/FEN1 pathway
Suwei Dong, Yanbin Xiao, Ziqiang Zhu, et al.
European Journal of Histochemistry (2023) Vol. 67, Iss. 2
Open Access | Times Cited: 1
Suwei Dong, Yanbin Xiao, Ziqiang Zhu, et al.
European Journal of Histochemistry (2023) Vol. 67, Iss. 2
Open Access | Times Cited: 1
